Diabetes and obesity-related genes and the risk of neural tube defects in the national birth defects prevention study

American Journal of Epidemiology

Volumn 176, Issue 12, 2012, Pages 1101-1109

  Lupo, Philip J ^a   Canfield, Mark A ^b   Chapa, Claudia ^c   Lu, Wei ^c   Agopian, A J ^a   Mitchell, Laura E ^a   Shaw, Gary M ^d   Kim Waller, D ^e   Olshan, Andrew F ^f   Finnell, Richard H ^c   Zhu, Huiping ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^f IL   (United States)

Author keywords

case parent triads; diabetes; genetics; neural tube defects; obesity

Indexed keywords

DIABETES; GENETIC VARIATION; GENOTYPE; HEALTH RISK; HOMEOSTASIS; OBESITY; POLYMORPHISM; PUBLIC HEALTH; RISK FACTOR;

ADULT; ARTICLE; BIRTH DEFECT; DIABETES MELLITUS; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE HOMEOSTASIS; HEREDITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVENTION STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT, NEWBORN; LINEAR MODELS; MALE; NEURAL TUBE DEFECTS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREGNANCY COMPLICATIONS; RISK; UNITED STATES;

EID: 84871209371     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws190     Document Type: Article

References (67)

1. Campbell LR, Dayton DH, Sohal GS. Neural tube defects: a review of human and animal studies on the etiology of neural tube defects. Teratology. 1986;34(2): 171-187.
2. Ouyang L, Grosse SD, Armour BS, et al. Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Res A Clin Mol Teratol. 2007;79(7):552-558.
3. Shaw GM, Todoroff K, Finnell RH, et al. Spina bifida phenotypes in infants or fetuses of obese mothers. Teratology. 2000;61(5):376-381.
4. Shaw GM, Velie EM, Schaffer D. Risk of neural tube defectaffected pregnancies among obese women. JAMA. 1996; 275(14):1093-1096.
5. Watkins ML, Rasmussen SA, Honein MA, et al. Maternal obesity and risk for birth defects. Pediatrics. 2003; 111(5):1152-1158.
6. Watkins ML, Scanlon KS, Mulinare J, et al. Is maternal obesity a risk factor for anencephaly and spina bifida? Epidemiology. 1996;7(5):507-512.
7. Soler NG, Walsh CH, Malins JM. Congenital malformations in infants of diabetic mothers. Q J Med. 1976;45(178): 303-313.
8. Waller DK, Shaw GM, Rasmussen SA, et al. Prepregnancy obesity as a risk factor for structural birth defects. National Birth Defects Prevention Study. Arch Pediatr Adolesc Med. 2007;161(8):745-750.
9. Waller DK, Mills JL, Simpson JL, et al. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol. 1994;170(2):541-548.
10. Hendricks KA, Nuno OM, Suarez L, et al. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology. 2001;12(6):630-635.
11. Werler MM, Louik C, Shapiro S, et al. Prepregnant weight in relation to risk of neural tube defects. JAMA. 1996;275(14): 1089-1092.
12. Källén K. Maternal smoking, body mass index, and neural tube defects. Am J Epidemiol. 1998;147(12):1103-1111.
13. Cabrera RM, Hill DS, Etheredge AJ, et al. Investigations into the etiology of neural tube defects. Birth Defects Res C Embryo Today. 2004;72(4):330-344.
14. Andreasen KR, Andersen ML, Schantz AL. Obesity and pregnancy. Acta Obstet Gynecol Scand. 2004;83(11): 1022-1029.
15. Carmichael SL, Rasmussen SA, Shaw GM. Prepregnancy obesity: a complex risk factor for selected birth defects. Birth Defects Res A Clin Mol Teratol. 2010;88(10):804-810.
16. King JC. Maternal obesity, metabolism, and pregnancy outcomes. Annu Rev Nutr. 2006;26:271-291.
17. Ray JG, Thompson MD, Vermeulen MJ, et al. Metabolic syndrome features and risk of neural tube defects. BMC Pregnancy Childbirth. 2007;7:21. (doi:10.1186/1471-2393-7-21).
18. Scialli AR. Teratology Public Affairs Committee position paper: maternal obesity and pregnancy. Birth Defects Res A Clin Mol Teratol. 2006;76(2):73-77.
19. Jovanovic-Peterson L, Peterson CM. Abnormal metabolism and the risk for birth defects with emphasis on diabetes. Ann N Y Acad Sci. 1993;678:228-243.
20. Trocino RA, Akazawa S, Takino H, et al. Cellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period. Endocrinology. 1994;134(2):869-878.
21. Maeda Y, Akazawa S, Akazawa M, et al. Glucose transporter gene expression in rat conceptus during early organogenesis and exposure to insulin-induced hypoglycemic serum. Acta Diabetol. 1993;30(2):73-78.
22. Takao Y, Akazawa S, Matsumoto K, et al. Glucose transporter gene expression in rat conceptus during high glucose culture. Diabetologia. 1993;36(8):696-706.
23. Zeggini E, McCarthy MI. TCF7L2: the biggest story in diabetes genetics since HLA? Diabetologia. 2007;50(1):1-4.
24. Tung YC, Yeo GS. From GWAS to biology: lessons from FTO. Ann N Y Acad Sci. 2011;1220(1):162-171.
25. Carter TC, Pangilinan F, Troendle JF, et al. Evaluation of 64 candidate single nucleotide polymorphisms as risk factors for neural tube defects in a large Irish study population. Am J Med Genet A. 2011;155A(1):14-21.
26. Davidson CM, Northrup H, King TM, et al. Genes in glucose metabolism and association with spina bifida. Reprod Sci. 2008;15(1):51-58.
27. Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public Health Rep. 2001; 116(suppl 1):32-40.
28. Rasmussen SA, Olney RS, Holmes LB, et al. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2003;67(3): 193-201.
29. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316(5829):1341-1345.
30. Volcik KA, Shaw GM, Zhu H, et al. Risk factors for neural tube defects: associations between uncoupling protein 2 polymorphisms and spina bifida. Birth Defects Res A Clin Mol Teratol. 2003;67(3):158-161.
31. Pizzuti A, Frittitta L, Argiolas A, et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes. 1999;48(9):1881-1884.
32. Ohnuma H, Yamatani K, Daimon M, et al. Impaired neural regulation of insulin secretion related to the leptin receptor gene mutation in Wistar fatty rats. Physiol Behav. 2000; 70(5):527-532.
33. Zhang Y, Wat N, Stratton IM, et al. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study. Diabetologia. 1996;39(12):1505-1511.
34. Nitz I, Ewert A, Klapper M, et al. Analysis of PGC-1α variants Gly482Ser and Thr612Met concerning their PPARγ2-coactivation function. Biochem Biophys Res Commun. 2007;353(2):481-486.
35. Li R, Thorens B, Loeken MR. Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy. Diabetologia. 2007;50(3):682-689.
36. Rasmussen SA, Lammer EJ, Shaw GM, et al. Integration of DNA sample collection into a multi-site birth defects casecontrol study. National Birth Defects Prevention Study. Teratology. 2002;66(4):177-184.
37. Weinberg CR, Wilcox AJ, Lie RT. A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet. 1998; 62(4):969-978.
38. Kistner EO, Weinberg CR. Method for using complete and incomplete trios to identify genes related to a quantitative trait. Genet Epidemiol. 2004;27(1):33-42.
39. Vermunt JK. LEM: A General Program for the Analysis of Categorical Data. Tilberg, the Netherlands: Tilberg University; 1997.
40. Weinberg CR. Allowing for missing parents in genetic studies of case-parent triads. Am J Hum Genet. 1999; 64(4):1186-1193.
41. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57(1):289-300.
42. Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39(6):724-726.
43. Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007; 3(7):e115. (doi:10.1371/journal.pgen.0030115).
44. Peng S, Zhu Y, Xu F, et al. FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med. 2011;9:71. (doi:10.1186/1741-7015-9-71).
45. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-894.
46. Wing MR, Ziegler JM, Langefeld CD, et al. Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort. Int J Obes (Lond). 2011;35(9):1173- 1182.
47. Nock NL, Plummer SJ, Thompson CL, et al. FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans. Carcinogenesis. 2011;32(5):748-756.
48. Chauhan G, Tabassum R, Mahajan A, et al. Common variants of FTO and the risk of obesity and type 2 diabetes in Indians. J Hum Genet. 2011;56(10):720-726.
49. Berulava T, Horsthemke B. The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. Eur J Hum Genet. 2010;18(9):1054- 1056.
50. Groop L. From fused toes in mice to human obesity. Nat Genet. 2007;39(6):706-707.
51. Fawcett KA, Barroso I. The genetics of obesity: FTO leads the way. Trends Genet. 2010;26(6):266-274.
52. Meyre D, Proulx K, Kawagoe-Takaki H, et al. Prevalence of loss-of-function FTO mutations in lean and obese individuals. Diabetes. 2010;59(1):311-318.
53. Mojtabai R. Body mass index and serum folate in childbearing age women. Eur J Epidemiol. 2004;19(11):1029-1036.
54. Hansson O, Zhou Y, Renström E, et al. Molecular function of TCF7L2: consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes. Curr Diab Rep. 2010;10(6):444-451.
55. Shu L, Sauter NS, Schulthess FT, et al. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes. 2008;57(3):645-653.
56. Shu L, Matveyenko AV, Kerr-Conte J, et al. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP-and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet. 2009; 18(13):2388-2399.
57. da Silva Xavier G, Loder MK, McDonald A, et al. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes. 2009;58(4):894-905.
58. Lehman DM, Hunt KJ, Leach RJ, et al. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes. 2007; 56(2):389-393.
59. Gautron L, Elmquist JK. Sixteen years and counting: an update on leptin in energy balance. J Clin Invest. 2011; 121(6):2087-2093.
60. Shaw GM, Barber R, Todoroff K, et al. Microsatellites proximal to leptin and leptin receptor as risk factors for spina bifida. Teratology. 2000;61(3):231-235.
61. Stark R, Roden M. ESCI Award 2006. Mitochondrial function and endocrine diseases. Eur J Clin Invest. 2007; 37(4):236-248.
62. Dalgaard LT. Genetic variance in uncoupling protein 2 in relation to obesity, type 2 diabetes, and related metabolic traits: focus on the functional-866G>A promoter variant (rs659366). J Obes. 2011;2011:340241. (doi:10.1155/2011/340241).
63. Martinez-Hervas S, Mansego ML, de Marco G, et al. Polymorphisms of the UCP2 gene are associated with body fat distribution and risk of abdominal obesity in Spanish population. Eur J Clin Invest. 2012;42(2):171-178.
64. Kosuge K, Soma M, Nakayama T, et al. Human uncoupling protein 2 and 3 genes are associated with obesity in Japanese. Endocrine. 2008;34(1-3):87-95.
65. Mitchell A, Pangilinan F, Van der Meer J, et al. Uncoupling protein 2 polymorphisms as risk factors for NTDs. Birth Defects Res A Clin Mol Teratol. 2009; 85(2):156-160.
66. Dempster AP Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc Ser B. 1977;39(1):1-28.
67. Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;199(3): 237.e1-237.e9.